256 related articles for article (PubMed ID: 28857446)
1. Diagnostic accuracy of pre-treatment biopsy for grading cutaneous mast cell tumours in dogs.
Shaw T; Kudnig ST; Firestone SM
Vet Comp Oncol; 2018 Jun; 16(2):214-219. PubMed ID: 28857446
[TBL] [Abstract][Full Text] [Related]
2. Comparison of 2- and 3-category histologic grading systems for predicting the presence of metastasis at the time of initial evaluation in dogs with cutaneous mast cell tumors: 386 cases (2009-2014).
Stefanello D; Buracco P; Sabattini S; Finotello R; Giudice C; Grieco V; Iussich S; Tursi M; Scase T; Di Palma S; Bettini G; Ferrari R; Martano M; Gattino F; Marrington M; Mazzola M; Elisabetta Vasconi M; Annoni M; Marconato L
J Am Vet Med Assoc; 2015 Apr; 246(7):765-9. PubMed ID: 25794126
[TBL] [Abstract][Full Text] [Related]
3. Expression of Ki67, BCL-2, and COX-2 in canine cutaneous mast cell tumors: association with grading and prognosis.
Vascellari M; Giantin M; Capello K; Carminato A; Morello EM; Vercelli A; Granato A; Buracco P; Dacasto M; Mutinelli F
Vet Pathol; 2013 Jan; 50(1):110-21. PubMed ID: 22673539
[TBL] [Abstract][Full Text] [Related]
4. Cytologic Criteria for Mast Cell Tumor Grading in Dogs With Evaluation of Clinical Outcome.
Camus MS; Priest HL; Koehler JW; Driskell EA; Rakich PM; Ilha MR; Krimer PM
Vet Pathol; 2016 Nov; 53(6):1117-1123. PubMed ID: 27034386
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic accuracy of pre-treatment biopsy for grading soft tissue sarcomas in dogs.
Perry JA; Culp WT; Dailey DD; Eickhoff JC; Kamstock DA; Thamm DH
Vet Comp Oncol; 2014 Jun; 12(2):106-13. PubMed ID: 22617002
[TBL] [Abstract][Full Text] [Related]
6. Epidemiological assessment of the risk of canine mast cell tumours based on the Kiupel two-grade malignancy classification.
Śmiech A; Ślaska B; Łopuszyński W; Jasik A; Bochyńska D; Dąbrowski R
Acta Vet Scand; 2018 Nov; 60(1):70. PubMed ID: 30390687
[TBL] [Abstract][Full Text] [Related]
7. Histologic grading of canine mast cell tumor: is 2 better than 3?
Sabattini S; Scarpa F; Berlato D; Bettini G
Vet Pathol; 2015 Jan; 52(1):70-3. PubMed ID: 24513799
[TBL] [Abstract][Full Text] [Related]
8. Validation of the prognostic value of histopathological grading or c-kit mutation in canine cutaneous mast cell tumours: a retrospective cohort study.
Takeuchi Y; Fujino Y; Watanabe M; Takahashi M; Nakagawa T; Takeuchi A; Bonkobara M; Kobayashi T; Ohno K; Uchida K; Asano K; Nishimura R; Nakayama H; Sugano S; Ohashi Y; Tsujimoto H
Vet J; 2013 Jun; 196(3):492-8. PubMed ID: 23384436
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical and clinical evaluation of p53 in canine cutaneous mast cell tumors.
Jaffe MH; Hosgood G; Taylor HW; Kerwin SC; Hedlund CS; Lopez MK; Davidson JR; Miller DM; Paranjpe M
Vet Pathol; 2000 Jan; 37(1):40-6. PubMed ID: 10643979
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of exon 11 internal tandem duplications in the C-KIT proto-oncogene in Australian canine mast cell tumours.
Tamlin VS; Kessell AE; Mccoy RJ; Dobson EC; Smith TS; Hebart M; Brown L; Mitrovic D; Peaston AE
Aust Vet J; 2017 Oct; 95(10):386-391. PubMed ID: 28948627
[TBL] [Abstract][Full Text] [Related]
11. Impact of tumour depth, tumour location and multiple synchronous masses on the prognosis of canine cutaneous mast cell tumours.
Kiupel M; Webster JD; Miller RA; Kaneene JB
J Vet Med A Physiol Pathol Clin Med; 2005 Aug; 52(6):280-6. PubMed ID: 16050909
[TBL] [Abstract][Full Text] [Related]
12. Cytological grading of canine cutaneous mast cell tumours.
Scarpa F; Sabattini S; Bettini G
Vet Comp Oncol; 2016 Sep; 14(3):245-51. PubMed ID: 24717019
[TBL] [Abstract][Full Text] [Related]
13. Advances in the diagnosis and management of cutaneous mast cell tumours in dogs.
Dobson JM; Scase TJ
J Small Anim Pract; 2007 Aug; 48(8):424-31. PubMed ID: 17559522
[TBL] [Abstract][Full Text] [Related]
14. Retrospective outcome evaluation for dogs with surgically excised, solitary Kiupel high-grade, cutaneous mast cell tumours.
Moore AS; Frimberger AE; Taylor D; Sullivan N
Vet Comp Oncol; 2020 Sep; 18(3):402-408. PubMed ID: 31916687
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of a two-centimeter lateral surgical margin for excision of grade I and grade II cutaneous mast cell tumors in dogs.
Fulcher RP; Ludwig LL; Bergman PJ; Newman SJ; Simpson AM; Patnaik AK
J Am Vet Med Assoc; 2006 Jan; 228(2):210-5. PubMed ID: 16426187
[TBL] [Abstract][Full Text] [Related]
16. Variation among pathologists in histologic grading of canine cutaneous mast cell tumors.
Northrup NC; Harmon BG; Gieger TL; Brown CA; Carmichael KP; Garcia A; Latimer KS; Munday JS; Rakich PM; Richey LJ; Stedman NL; Cheng AL; Howerth EW
J Vet Diagn Invest; 2005 May; 17(3):245-8. PubMed ID: 15945380
[TBL] [Abstract][Full Text] [Related]
17. Analysis of risk factors for canine mast cell tumors based on the Kiupel and Patnaik grading system among dogs with skin tumors.
Martins AL; Carvalho FF; Mesquita JR; Gärtner F; Amorim I
Open Vet J; 2021; 11(4):619-634. PubMed ID: 35070857
[TBL] [Abstract][Full Text] [Related]
18. What is your diagnosis? Mast cell sarcoma.
Dunn K
J Small Anim Pract; 1997 Mar; 38(3):93, 108. PubMed ID: 9097238
[No Abstract] [Full Text] [Related]
19. What is your diagnosis? Mast cell tumour.
Hess M
J Small Anim Pract; 2006 Sep; 47(9):555-6. PubMed ID: 16961476
[No Abstract] [Full Text] [Related]
20. Expression of serotonin and its 5-HT1A receptor in canine cutaneous mast cell tumours.
Fröberg GK; Lindberg R; Ritter M; Nordlind K
J Comp Pathol; 2009; 141(2-3):89-97. PubMed ID: 19446835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]